Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an unmet kidney disease indication, today announced that it will present at Biotech Showcase™ 2020, to be held January 13–15, 2020 at the Hilton San Francisco ...

As New Mexico celebrates its 108th anniversary of statehood, a new Emerson College Poll finds New Mexico Democratic primary voters split between Senator Bernie Sanders at 28% and former V.P. Joe Biden at 27%. Entrepreneur Andrew Yang is the only other candidate in double figur...

January 6, 2020 -- AIM Biotech announced that its founder, Professor Roger Kamm, was awarded The Shu Chien Scientific Achievement Award. The award was granted by the Biomedical Engineering Society's Cellular and Molecular Bioengineering SIG in recognition of Prof Kamm's contri...

QuaraSense™ is an entirely new technology platform that will measure the signature of infectious bacteria, enabling rapid response and greater chance for stopping an infection. Treatment efficacy may be measured on an ongoing basis.  This will also be the first platform capab...

Holliston, MA – January 2, 2020 – Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), a bioengineering company developing next-generation esophageal implants, received the anticipated formal response from the U.S. Food and Drug Administration (FDA) related to the Compa...

Boston, MA -- January 5, 2020 -- Techlobe raised $24 million in a Series B financing, The round was led by Prospect Bay Ventures with participation from existing investors. Techlobe offers you great new ways to manage all the noise in life to effectively navigate the world in ...

[Seoul/December 31, 2019] – MD Healthcare Inc. today announced that it has scheduled a company presentation at Biotech Showcase™ 2020, to be held January 13–15, during the most important week in healthcare at the Hilton San Francisco Union Square. B&D Specialist Andrea McDowel...

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biotechnology company targeting cancers caused by mis-regulated gene expression, referred to as epigenetics, has announced that its chief executive officer, David Arthur, will present at the Biotech Showcase 2020 ...

NanoValent continues to progress towards its goal of moving our lead drug candidate to an IND/BLA and the clinic in 2021 and 2022. Although our “almost virtual” infrastructure has us sheltering-in-place as a regular course of business, these are by no means normal times.  Yet,...

Berwyn, PA – DEC. 24, 2019 – CuRAGE Therapeutics announced today that it is scheduled to deliver a company presentation at Biotech Showcase™ 2020, to be held January 13–15, during the most important week in healthcare at the Hilton San Francisco Union Square. Dr. Ihor Terlecky...